Clinical Trials Browser

Phase 2 × Brentuximab Vedotin × Myeloid × Clear all

Leukemia, Mast-Cell, Mastocytosis, Systemic

NCT01461538 2016-03-04

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Hematologic Diseases, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia

Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies